Artificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy public health measures.
AAC recently published a commentary on the impact of AI in infectious diseases and we have a conversation with the lead author of the manuscript and a expert guest who is applying these concepts in real time.
Topics discussed:
- Basic concepts of AI and different applications.
- How AI can affect the practice of infectious diseases and antimicrobial research.
- Specific examples in which AI may have a transformative effect in the future.
Guests:
- Lilian Abbo, MD MBA. Associate CMO Infectious Diseases, Professor of Clinical Infectious Diseases, Jackson Health System, University of Miami Miller School of Medicine, Miami Transplant Institute
- Masayuki Nigo, MD, MSc. Associate Professor of Clinical Medicine, Houston Methodist Hospital, Section of Transplant Infectious Diseases.
Links:
This episode is brought to you by the Antimicrobial Agents and Chemotherapy journal available at . If you plan to publish in AAC, ASM Members get up to 50% off publishing fees. Visit asm.org/membership to sign up.
Visit to browse issues and/or submit a manuscript.
Subscribe to Editors in Conversation (free) on , , , .